Back to AVTX

Avalo Therapeutics, Inc. 10-K

Accession 0001628280-21-004162

Filing information

CIK
0001534120
Report date
2020-12-31
Filing date
2021-03-08
Form
10-K
Primary document
cerc-20201231.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.